Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 41

Results For "CROs"

4242 News Found

Sun Pharma reports FY26 revenue of Rs. 58,220 crore, net profit at Rs. 11,479 crore
News | May 22, 2026

Sun Pharma reports FY26 revenue of Rs. 58,220 crore, net profit at Rs. 11,479 crore

Q4FY26 revenue rises 13.6% to Rs. 14,560 crore; quarterly net profit jumps 26.2% to Rs. 2,714 crore driven by India business and Innovative Medicines growth


Jubilant Pharmova posts 14% FY26 revenue growth to Rs. 8,280 crore amid margin pressure
News | May 22, 2026

Jubilant Pharmova posts 14% FY26 revenue growth to Rs. 8,280 crore amid margin pressure

Q4FY26 revenue climbs 19% to Rs. 2,290 crore as CDMO sterile injectables, radiopharma and generics businesses drive growth momentum


Boehringer Ingelheim India signs MoUs with NIPER Ahmedabad and Hyderabad to expand research collaboration
R&D | May 21, 2026

Boehringer Ingelheim India signs MoUs with NIPER Ahmedabad and Hyderabad to expand research collaboration

This collaboration across the NIPER network- Raebareli, Hajipur, Ahmedabad and Hyderabad is strengthening translational research and opnMe access


Apollo, Cloudnine merge maternity and fertility businesses in Rs. 1,550 crore deal
Hospitals | May 21, 2026

Apollo, Cloudnine merge maternity and fertility businesses in Rs. 1,550 crore deal

Combined platform with 55+ centres aims to expand integrated maternity, fertility, neonatal and paediatric care across India


Drug Safety Symposium 2026 to focus on real-world impact of pharmacovigilance
News | May 21, 2026

Drug Safety Symposium 2026 to focus on real-world impact of pharmacovigilance

The event is expected to attract more than 100 senior professionals from pharmaceutical companies, CROs, regulatory agencies, and technology organisations


Pfizer advances next-gen pneumococcal vaccine after strong Phase 2 infant data
Clinical Trials | May 21, 2026

Pfizer advances next-gen pneumococcal vaccine after strong Phase 2 infant data

Pfizer says the broader dataset across all 25 serotypes strengthens confidence that the program can meet non-inferiority thresholds in its upcoming Phase 3 pediatric trials


Dr. Abhigyan Upadhyay to lead Platinum Industries foray into life sciences
People | May 21, 2026

Dr. Abhigyan Upadhyay to lead Platinum Industries foray into life sciences

Dr. Upadhyay brings over 25 years of global leadership experience across life sciences, regulated manufacturing, diagnostics, and research-led environments


QIAGEN and NVIDIA partner on AI drug discovery
R&D | May 21, 2026

QIAGEN and NVIDIA partner on AI drug discovery

Collaboration integrates NVIDIA accelerated computing and the NVIDIA BioNeMo platform with QIAGEN Digital Insights’ curated biomedical knowledge bases


Hansa Biopharma licenses IDEFIRIX to SERB Pharmaceuticals in €115 million deal
News | May 21, 2026

Hansa Biopharma licenses IDEFIRIX to SERB Pharmaceuticals in €115 million deal

SERB has a substantial European commercial presence and a successful track record in critical care and rare disease commercialization


India reaffirms commitment to global women and child health agenda at WHA 2026
Policy | May 21, 2026

India reaffirms commitment to global women and child health agenda at WHA 2026

Minister J.P. Nadda holds bilateral meeting with Helen Clark, Board Chair of the Partnership for Maternal, Newborn and Child Health in Geneva